These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22052099)

  • 21. Quercetin inhibits swarming motility and activates biofilm production of Proteus mirabilis possibly by interacting with central regulators, metabolic status or active pump proteins.
    Aygül A; Öztürk İ; Çilli FF; Ermertcan Ş
    Phytomedicine; 2019 Apr; 57():65-71. PubMed ID: 30668324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on the adherence of Proteus mirabilis onto polymer surfaces.
    Stickler DJ; Lear JC; Morris NS; Macleod SM; Downer A; Cadd DH; Feast WJ
    J Appl Microbiol; 2006 May; 100(5):1028-33. PubMed ID: 16630003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation.
    Ferrières L; Hancock V; Klemm P
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):212-9. PubMed ID: 17645737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Into the understanding the multicellular lifestyle of
    Gmiter D; Kaca W
    Front Cell Infect Microbiol; 2022; 12():864305. PubMed ID: 36118021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL; Island MD; Massad G
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of biofilm formation by Proteus mirabilis strains on the surface of different biomaterials by two methods].
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    Med Dosw Mikrobiol; 2011; 63(2):131-8. PubMed ID: 22184907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proteus mirabilis isolated from urine, resistance to antibiotics and biofilm formation].
    Cernohorská L; Chvílová E
    Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):81-5. PubMed ID: 21780025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
    Rocha SP; Elias WP; Cianciarullo AM; Menezes MA; Nara JM; Piazza RM; Silva MR; Moreira CG; Pelayo JS
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
    Zunino P; Piccini C; Legnani-Fajardo C
    Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical assessment of the performance of a sensor to detect crystalline biofilm formation on indwelling bladder catheters.
    Stickler DJ; Jones SM; Adusei GO; Waters MG; Cloete J; Mathur S; Feneley RC
    BJU Int; 2006 Dec; 98(6):1244-9. PubMed ID: 17026594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteus mirabilis biofilms and catheter-associated urinary tract infections.
    Jacobsen SM; Shirtliff ME
    Virulence; 2011; 2(5):460-5. PubMed ID: 21921687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan.
    Jones GL; Russell AD; Caliskan Z; Stickler DJ
    Eur Urol; 2005 Nov; 48(5):838-45. PubMed ID: 16126323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fimbriae have distinguishable roles in Proteus mirabilis biofilm formation.
    Scavone P; Iribarnegaray V; Caetano AL; Schlapp G; Härtel S; Zunino P
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27091004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fimbriae of uropathogenic Proteus mirabilis.
    Rocha SP; Pelayo JS; Elias WP
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms.
    Stickler DJ
    J Appl Microbiol; 2002; 92 Suppl():163S-70S. PubMed ID: 12000625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A model of catheter-associated urinary tract infection initiated by bacterial contamination of the catheter tip.
    Barford JM; Anson K; Hu Y; Coates AR
    BJU Int; 2008 Jul; 102(1):67-74. PubMed ID: 18284413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter induced urethral inflammatory reaction and urinary tract infection. An experimental and clinical study.
    Liedberg H
    Scand J Urol Nephrol Suppl; 1989; 124():1-43. PubMed ID: 2633310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotyping demonstrates that the strains of Proteus mirabilis from bladder stones and catheter encrustations of patients undergoing long-term bladder catheterization are identical.
    Sabbuba NA; Stickler DJ; Mahenthiralingam E; Painter DJ; Parkin J; Feneley RC
    J Urol; 2004 May; 171(5):1925-8. PubMed ID: 15076313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters.
    Pour NK; Dusane DH; Dhakephalkar PK; Zamin FR; Zinjarde SS; Chopade BA
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):328-38. PubMed ID: 21569125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary catheter capable of repeated on-demand removal of infectious biofilms via active deformation.
    Levering V; Cao C; Shivapooja P; Levinson H; Zhao X; López GP
    Biomaterials; 2016 Jan; 77():77-86. PubMed ID: 26584348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.